Resonant Capital Advisors’s MetLife MET Stock Holding History
Bought
Maintained
Sold
Other funds holding MET
Resonant Capital Advisors's MET Position: Q2 2026 in Review
Resonant Capital Advisors increased its MetLife (MET) stake by 0.72% in Q2 2026, buying an estimated $3.63K and bringing the position to 6,308 shares worth $534K. The position accounts for 0.03% of the portfolio, ranked #284.
Resonant Capital Advisors first reported a position in MET in Q1 2022 and has held it in 16 quarters since. 1,450 funds tracked by Wall St. Rank hold MET as of Q2 2026.
- Resonant Capital Advisors held 6,308 shares of MetLife worth $534K as of Q2 2026.
- Resonant Capital Advisors bought 45 MetLife shares in Q2 2026, an estimated $3.63K.
- MetLife made up 0.03% of Resonant Capital Advisors's portfolio in Q2 2026, its #284 holding.
- Resonant Capital Advisors first reported a position in MetLife in Q1 2022 and has held it in 16 quarters since.
- 1,450 funds tracked by Wall St. Rank held MetLife as of Q2 2026.
Based on Resonant Capital Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.